Progeria
6 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Phase I/II Trial of Everolimus in Combination With Lonafarnib in Progeria (NCT02579044) | Boston Children's Hospital | 2015-12-01 |
| Study of Zoledronic Acid, Pravastatin, and Lonafarnib for Patients With Progeria (NCT00916747) | Boston Children's Hospital | 2009-08-01 |
| Phase II Trial of Lonafarnib (a Farnesyltransferase Inhibitor) for Progeria (NCT00425607) | Monica E. Kleinman | 2007-05-01 |
| Clinical Studies of Progeria (NCT00094393) | National Human Genome Research Institute (NHGRI) | 2004-10-14 |
| Lonafarnib for Patients With Hutchinson-Gilford Progeria Syndrome or Progeroid Laminopathy (NCT03895528) | Eiger BioPharmaceuticals |
Track Progeria automatically
Every clearance here is in the API, with alerts when new ones post.